226 related articles for article (PubMed ID: 16638606)
1. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy SS; Perez A; Koller BH; Duncan GE
Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
[TBL] [Abstract][Full Text] [Related]
2. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
[TBL] [Abstract][Full Text] [Related]
3. Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity.
van den Buuse M; Halley P; Hill R; Labots M; Martin S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jun; 37(2):237-46. PubMed ID: 22361156
[TBL] [Abstract][Full Text] [Related]
4. Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice.
van den Buuse M; van Driel IR; Samuelson LC; Pijnappel M; Martin S
Neurosci Lett; 2005 Jan; 373(3):237-42. PubMed ID: 15619550
[TBL] [Abstract][Full Text] [Related]
5. Prepulse inhibition of the acoustic startle reflex in pigs and its disruption by d-amphetamine.
Lind NM; Arnfred SM; Hemmingsen RP; Hansen AK
Behav Brain Res; 2004 Dec; 155(2):217-22. PubMed ID: 15364480
[TBL] [Abstract][Full Text] [Related]
6. A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle.
Brody SA; Nakanishi N; Tu S; Lipton SA; Geyer MA
Biol Psychiatry; 2005 May; 57(10):1147-52. PubMed ID: 15866554
[TBL] [Abstract][Full Text] [Related]
7. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
8. Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: effects of drug administration regimen.
Li M; He W; Chen J
Pharmacol Biochem Behav; 2011 Sep; 99(3):509-18. PubMed ID: 21600239
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme (ACE) interacts with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice.
van den Buuse M; Zheng TW; Walker LL; Denton DA
Neurosci Lett; 2005 May 20-27; 380(1-2):6-11. PubMed ID: 15854741
[TBL] [Abstract][Full Text] [Related]
10. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice.
Ralph RJ; Paulus MP; Geyer MA
J Pharmacol Exp Ther; 2001 Jul; 298(1):148-55. PubMed ID: 11408536
[TBL] [Abstract][Full Text] [Related]
12. Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?
Martin S; Markus MA; Morris BJ; Davisson RL; Lawrence AJ; van den Buuse M
Neuropharmacology; 2008 Feb; 54(2):399-404. PubMed ID: 18037452
[TBL] [Abstract][Full Text] [Related]
13. Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice.
Dean O; Bush AI; Berk M; Copolov DL; van den Buuse M
Pharmacol Biochem Behav; 2010 Dec; 97(2):293-300. PubMed ID: 20816888
[TBL] [Abstract][Full Text] [Related]
14. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.
al-Amin HA; Schwarzkopf SB
Biol Psychiatry; 1996 Oct; 40(8):744-54. PubMed ID: 8894067
[TBL] [Abstract][Full Text] [Related]
15. Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities.
Wolf R; Dobrowolny H; Matzke K; Paelchen K; Bogerts B; Schwegler H
Behav Brain Res; 2006 Jan; 166(1):78-84. PubMed ID: 16169608
[TBL] [Abstract][Full Text] [Related]
16. Endogenous kynurenic acid disrupts prepulse inhibition.
Erhardt S; Schwieler L; Emanuelsson C; Geyer M
Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
[TBL] [Abstract][Full Text] [Related]
17. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
18. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
[TBL] [Abstract][Full Text] [Related]
19. Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice.
Gould TJ; Rukstalis M; Lewis MC
Neurosci Lett; 2005 Mar; 377(2):85-90. PubMed ID: 15740842
[TBL] [Abstract][Full Text] [Related]
20. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
